December 09, 2025
Back to all stories

Ohio surgeon indicted; license suspended

An Ohio grand jury indicted University of Toledo surgical resident Hassan‑James Abbas, 32, on Dec. 3 on six felony counts after authorities say he crushed abortion pills and attempted to force them into his pregnant girlfriend’s mouth as she slept. The State Medical Board of Ohio summarily suspended his license on Nov. 5, citing immediate danger to the public, and scheduled a disciplinary hearing for May 14–15, 2026; the university says he is on administrative leave and will cooperate with the board.

Abortion and Reproductive Health Law Medical Licensing and Discipline

📌 Key Facts

  • Indictment (Dec. 3, 2025): abduction; tampering with evidence; unlawful distribution of an abortion-inducing drug; disrupting public services; identity fraud; deception to obtain a dangerous drug
  • State Medical Board of Ohio issued a Notice of Opportunity for Hearing and Summary Suspension on Nov. 5, 2025
  • Board hearing set for May 14–15, 2026; Abbas barred from practicing medicine pending outcome
  • Allegation includes ordering mifepristone and misoprostol using estranged wife’s identity and attempting to administer crushed pills
  • University of Toledo placed Abbas on administrative leave; Fox News Digital contacted his attorney

📊 Relevant Data

In 2021, the abortion rate was 28.6 abortions per 1,000 non-Hispanic Black women aged 15-44, 12.3 per 1,000 Hispanic women, and 6.4 per 1,000 non-Hispanic White women, while non-Hispanic Black people make up about 13.6% of the U.S. population, Hispanics 18.9%, and non-Hispanic Whites 59.3%.

What the data says about abortion in the U.S. — Pew Research Center

Racial disparities in abortion rates are related to racial/ethnic and socioeconomic disparities in unintended pregnancy rates.

Disparities in Abortion Rates: A Public Health Approach — PMC - NCBI

As of December 2022, there have been 32 reported deaths associated with mifepristone use out of approximately 5.9 million patients who have used the drug since its approval in 2000.

Mifepristone U.S. Post-Marketing Adverse Events Summary through 12/2022 — FDA

Approximately one in eight females aged 14-45 reported experiencing recent reproductive coercion, with no significant demographic differences observed.

Reproductive Coercion and Relationship Abuse Among Adolescents and Young Women Seeking Care at School Health Centers — Obstetrics & Gynecology